Monascus-Fermented Products

T. M. Pan; W. H. Hsu

doi:10.1016/B978-0-12-384730-0.00226-3

Monascus-Fermented Products

T. M. Pan, W. H. Hsu

Department of Food Safety / Hygiene and Risk Management

Research output: Chapter in Book/Report/Conference proceeding › Chapter

15 Citations (Scopus)

Abstract

Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including pigments, monacolins, dimerumic acid, and γ-aminobutyric acid. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, antioxidative, and antitumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer. The current article discusses and provides evidence to support the beneficial potential of Monascus-fermented metabolites in iatrical prevention.

Original language	English
Title of host publication	Encyclopedia of Food Microbiology
Subtitle of host publication	Second Edition
Publisher	Elsevier Inc.
Pages	815-825
Number of pages	11
ISBN (Electronic)	9780123847331
ISBN (Print)	9780123847300
DOIs	https://doi.org/10.1016/B978-0-12-384730-0.00226-3
Publication status	Published - 2014 Apr 2

All Science Journal Classification (ASJC) codes

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-384730-0.00226-3

Cite this

@inbook{d55dbf47faa4497e8cefd1f5889d62c4,

title = "Monascus-Fermented Products",

abstract = "Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including pigments, monacolins, dimerumic acid, and γ-aminobutyric acid. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, antioxidative, and antitumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer. The current article discusses and provides evidence to support the beneficial potential of Monascus-fermented metabolites in iatrical prevention.",

author = "Pan, {T. M.} and Hsu, {W. H.}",

year = "2014",

month = apr,

day = "2",

doi = "10.1016/B978-0-12-384730-0.00226-3",

language = "English",

isbn = "9780123847300",

pages = "815--825",

booktitle = "Encyclopedia of Food Microbiology",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Monascus-Fermented Products

AU - Pan, T. M.

AU - Hsu, W. H.

PY - 2014/4/2

Y1 - 2014/4/2

N2 - Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including pigments, monacolins, dimerumic acid, and γ-aminobutyric acid. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, antioxidative, and antitumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer. The current article discusses and provides evidence to support the beneficial potential of Monascus-fermented metabolites in iatrical prevention.

AB - Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including pigments, monacolins, dimerumic acid, and γ-aminobutyric acid. Several scientific studies have shown that these secondary metabolites have anti-inflammatory, antioxidative, and antitumor activities. Moreover, many published reports have shown the efficacy of Monascus-fermented products in the prevention or amelioration of some diseases, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, obesity, Alzheimer's disease, and numerous types of cancer. The current article discusses and provides evidence to support the beneficial potential of Monascus-fermented metabolites in iatrical prevention.

UR - http://www.scopus.com/inward/record.url?scp=84962007441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962007441&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-384730-0.00226-3

DO - 10.1016/B978-0-12-384730-0.00226-3

M3 - Chapter

AN - SCOPUS:84962007441

SN - 9780123847300

SP - 815

EP - 825

BT - Encyclopedia of Food Microbiology

PB - Elsevier Inc.

ER -

Monascus-Fermented Products

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this